PTX3 and Parkinson disease: Collectively, these findings showcase the potential of targeting apoptotic cascades in PD, whether through the action of specific proteins such as PTX3, pharmacological modulation via ROCK inhibition, or the deployment of tissue stem cell-derived exosomal products.